338 related articles for article (PubMed ID: 14587198)
1. [Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front].
MMW Fortschr Med; 2003 Jul; 145(27-28):63. PubMed ID: 14587198
[No Abstract] [Full Text] [Related]
2. [Osteoporosis therapy compared. More solid bones with bisphosphonates].
MMW Fortschr Med; 2003 Aug; 145(31-32):55. PubMed ID: 14524081
[No Abstract] [Full Text] [Related]
3. [First choice drug for treatment of osteoporosis and the strategic points for choice of drugs].
Soen S
Nihon Rinsho; 2007 Nov; 65 Suppl 9():325-8. PubMed ID: 18159713
[No Abstract] [Full Text] [Related]
4. [Combination therapy for osteoporosis].
Hagino H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():316-20. PubMed ID: 18161124
[No Abstract] [Full Text] [Related]
5. [Therapeutic strategies for osteoporosis].
Chapurlat R; Delmas PD
Ann Med Interne (Paris); 2000 Oct; 151(6):471-6. PubMed ID: 11104926
[TBL] [Abstract][Full Text] [Related]
6. Drugs for prevention and treatment of postmenopausal osteoporosis.
Treat Guidel Med Lett; 2002 Nov; 1(3):13-8. PubMed ID: 15529101
[No Abstract] [Full Text] [Related]
7. [Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].
Ohta H
Clin Calcium; 2008 Oct; 18(10):1442-50. PubMed ID: 18830041
[TBL] [Abstract][Full Text] [Related]
8. [Evidence of raloxifene on postmenopausal osteoporosis].
Okano H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():374-80. PubMed ID: 18161135
[No Abstract] [Full Text] [Related]
9. [Treatment of osteoporosis with antiresorptive drugs].
Vestergaard P; Mosekilde L; Brixen K
Ugeskr Laeger; 2005 Feb; 167(8):883-7. PubMed ID: 15789840
[No Abstract] [Full Text] [Related]
10. Advances in osteoporosis therapy. 2003 update of practical guidelines.
Khan A
Can Fam Physician; 2003 Apr; 49():441-7. PubMed ID: 12729240
[TBL] [Abstract][Full Text] [Related]
11. [Osteoporosis - Evidence based therapy].
Minne HW; Begerow B; Pfeifer M
Z Gastroenterol; 2002 Apr; 40 Suppl 1():S57-S61. PubMed ID: 11930292
[TBL] [Abstract][Full Text] [Related]
12. [New guideline for the treatment of osteoporosis].
Matsumoto T
Nihon Rinsho; 2004 Feb; 62 Suppl 2():387-91. PubMed ID: 15035157
[No Abstract] [Full Text] [Related]
13. [From effective to economical. The value of good osteoporosis therapy].
Minne HW; Pfeifer M; Pollähne W
MMW Fortschr Med; 2002 May; 144(21):30-3. PubMed ID: 12134421
[No Abstract] [Full Text] [Related]
14. [SERM for early osteoporosis therapy. Risk for first spinal fracture reduced to half].
MMW Fortschr Med; 2003 May; 145(22):57. PubMed ID: 12866287
[No Abstract] [Full Text] [Related]
15. Pharmacologic prevention of osteoporotic fractures.
Zizic TM
Am Fam Physician; 2004 Oct; 70(7):1293-300. PubMed ID: 15508540
[TBL] [Abstract][Full Text] [Related]
16. [Defining the role of raloxifene as a therapeutic agent for postmenopausal osteoporosis: focus on its pharmacological properties].
Ohta H
Clin Calcium; 2004 Oct; 14(10):73-80. PubMed ID: 15577135
[TBL] [Abstract][Full Text] [Related]
17. [Advance in the treatment of postmenopausal osteoporosis].
Akazawa K
Nihon Rinsho; 2002 Mar; 60 Suppl 3():298-305. PubMed ID: 11979922
[No Abstract] [Full Text] [Related]
18. [Effects of estrogen and selective estrogen receptor modulators on osteoporosis].
Urano T
Clin Calcium; 2005 Apr; 15(4):591-5. PubMed ID: 15802770
[TBL] [Abstract][Full Text] [Related]
19. Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial.
Lufkin EG; Sarkar S; Kulkarni PM; Ciaccia AV; Siddhanti S; Stock J; Plouffe L
Curr Med Res Opin; 2004 Mar; 20(3):351-7. PubMed ID: 15025844
[TBL] [Abstract][Full Text] [Related]
20. [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?].
MMW Fortschr Med; 2004 May; 146(21):63. PubMed ID: 15373093
[No Abstract] [Full Text] [Related]
[Next] [New Search]
